Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hemophilia A With Inhibitor”

80 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 80 results

Not applicableStudy completedNCT00166309
What this trial is testing

The FEIBA NovoSeven Comparative Study

Who this might be right for
Severe Hemophilia A With an Inhibitor
Skane University Hospital 60
Post-approval studies (Phase 4)Looking for participantsNCT06864975
What this trial is testing

Assessing Different FVIII Doses and Frequencies in Immune Tolerance Induction (ITI) with ADVATE Among Hemophilia a Boys with Inhibitor (INITIATE Study)

Who this might be right for
Hemophilia a with Inhibitor
Runhui WU 110
Post-approval studies (Phase 4)UnknownNCT04621916
What this trial is testing

Preventing Inhibitor Recurrence Indefinitely

Who this might be right for
Hemophilia AImmune Tolerance
Children's Hospital Los Angeles 52
Testing effectiveness (Phase 2)UnknownNCT04592692
What this trial is testing

A Pharmacokinetic and Clotting Activity Study of FVIII-PEGLip

Who this might be right for
Hemophilia A With Inhibitor
Ascension Healthcare Development Limited 20
Not applicableNot Yet RecruitingNCT07200609
What this trial is testing

The Effects of Virtual Reality-Based Gamified Rehabilitation in Children With Hemophilia

Who this might be right for
Hemophilia A Without Inhibitor
Hacettepe University 20
Early research (Phase 1)Study completedNCT04072237
What this trial is testing

Study of Coagulation Faction VIIa Variant Marzeptacog Alfa (Activated) in Adult Subjects With Hemophilia

Who this might be right for
Hemophilia AHemophilia BHemophilia A With Inhibitor+3 more
Catalyst Biosciences 11
Not applicableUnknownNCT04805801
What this trial is testing

The Safety of Emicizumab SC Injection in Korean Hemophilia A Patients With/Without FVIII Inhibitors

Who this might be right for
Hemophilia A With InhibitorHemophilia A Without Inhibitor
JW Pharmaceutical 17
Large-scale testing (Phase 3)Study completedNCT00375323
What this trial is testing

Recombinant Factor VIIa (NovoSeven) on Restoring Coagulation Activation

Who this might be right for
Hemophilia A
Medical University of Vienna
Large-scale testing (Phase 3)Study completedNCT03935334
What this trial is testing

Clinical Trial Comparing a Biosimilar Eptacog Alfa With Novoseven, in Patients With Hemophilia With Inhibitors

Who this might be right for
Hemophilia A or B With Inhibitor
AryoGen Pharmed Co. 48
Testing effectiveness (Phase 2)Active Not RecruitingNCT04684940
What this trial is testing

Safety, Tolerability, and Efficacy Study of Valoctocogene Roxaparvovec in Hemophilia A With Active or Prior Inhibitors

Who this might be right for
Hemophilia A With InhibitorHemophilia A With Anti Factor VIII
BioMarin Pharmaceutical 10
Not applicableUnknownNCT04106323
What this trial is testing

Factor Inhibitors in Adult Patients With Hemophilia and Von Willebrand's Disease in Upper Egypt

Who this might be right for
HemophiliaVon Willebrand DiseasesChristmas Disease
Safaa AA Khaled 100
Testing effectiveness (Phase 2)Study completedNCT00245245
What this trial is testing

Study of Recombinant Porcine Factor VIII (FVIII) in Hemophilia and Inhibitors to FVIII

Who this might be right for
Hemophilia A
Octagen Corporation 12
Early research (Phase 1)Study completedNCT05651061
What this trial is testing

A Phase I of SS109 in Hemophilia A or and B With Inhibitors

Who this might be right for
Hemophilia A With InhibitorHemophilia B With InhibitorFactor VII Deficiency
Jiangsu Gensciences lnc. 27
Not applicableStudy completedNCT03818529
What this trial is testing

ATHN 8: Previously Untreated Patients (PUPs) Matter Study

Who this might be right for
HemophiliaHemophilia AHemophilia B+5 more
American Thrombosis and Hemostasis Network 237
Large-scale testing (Phase 3)Ended earlyNCT04303572
What this trial is testing

The Hemophilia Inhibitor Eradication Trial

Who this might be right for
Hemophilia A With Inhibitor
Margaret Ragni 1
Not applicableLooking for participantsNCT05802836
What this trial is testing

Dynamics of the Anti-factor VIII Antibody Signature During Treatment With Emicizumab

Who this might be right for
Severe Hemophilia ASevere Hemophilia A With InhibitorSevere Hemophilia A Without Inhibitor
Christoph Königs 100
Not applicableStudy completedNCT01571934
What this trial is testing

Inhibitor Development in Patients With Hemophilia A Undergoing Surgery

Who this might be right for
Hemophilia A
Emory University 30
Large-scale testing (Phase 3)UnknownNCT05487976
What this trial is testing

Clinical Study of Recombinant Human Activated Coagulation Factor VII for Injection in Patients With Hemophilia With Inhibitor

Who this might be right for
Hemophilia AHemophilia B
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 50
Testing effectiveness (Phase 2)Study completedNCT06010953
What this trial is testing

SS109 and NovoSeven ® PK / PD Profile, and Preliminary Efficacy and Safety of SS109 on Demand Treatment

Who this might be right for
MaleHemophilia A With InhibitorHemophilia B With Inhibitor+1 more
Jiangsu Gensciences lnc. 24
Large-scale testing (Phase 3)Study completedNCT03417102
What this trial is testing

Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients With Inhibitors

Who this might be right for
Hemophilia AHemophilia B
Genzyme, a Sanofi Company 60
Load More Results